Uri Abadi

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 89 citations · Full text

Medicine, Hematology, Pharmacoeconomics +14

Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Adam J. Olszewski, Abraham Avigdor, Sunil Babu et al. · Blood · 2020 · 57 citations

Medicine, Oncology, Pharmacology +10

Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice

Arnon Nagler, Mark Pines, Uri Abadi et al. · Hepatology · 2000 · 42 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Mosunetuzumab Monotherapy Continues to Demonstrate Promising Efficacy and Durable Complete Responses in Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Adam J. Olszewski, Abraham Avigdor, Sunil Babu et al. · Blood · 2022 · 37 citations

Pharmacy, Oncology, Pharmacotherapy +6

Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience

Yafit Segman, Elena Ribakovsky, Abraham Avigdor et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 36 citations

Medicine, Oncology, Pharmacotherapy +16